On this page
The short answer. Stocks rose on Monday as oil prices fell and tech shares gained, CNBC reported, with the S&P 500 closing up 2.35%. Nvidia fell after its board said it is investigating reports about Jensen Huang, its chief executive, CNBC reported. The fall cut about $192 billion from Nvidia's market value, while chipmakers such as AMD and Broadcom rose. Elsewhere, Telos and Greenfire Resources jumped after company news, and Faeth Therapeutics fell after it reported early results from a mid-stage cancer trial.
The market at the close, Monday
Every company reporting the same week, with its date and time, is in StockTitan's Earnings Calendar for the Week of November 9, 2026.
Live updates
The newest update comes first, with the time it was written. Stock moves come from StockTitan's real-time data unless another source is named.
8:07 p.m. ET
Closing summary: the S&P 500 has its best day since April while Nvidia falls
Monday ended with a broad rally that Nvidia missed. Stocks rose as oil prices fell and tech shares gained, and the S&P 500 closed up 2.35%, its best day since April 8, CNBC reported. The Dow Jones Industrial Average gained 2.15% and the Nasdaq Composite rose 2.74%, it reported.
The funds that track the indexes rose too, StockTitan's daily closes show. SPY, the fund for the S&P 500, closed up 2.37%, and QQQ, the fund for the Nasdaq-100, rose 3.54%. DIA, the fund for the Dow, gained 2.17%. IWM, the fund for the Russell 2000 index of smaller companies, rose 3.23%.
Nvidia fell after its board opened an investigation into reports about Jensen Huang, its chief executive (NVIDIA board statement). Telos rose the most of the stocks in the movers table, after it raised its revenue forecast for 2026 (Telos results, SEC exhibit). Faeth Therapeutics fell the most of them, after it reported early results from a mid-stage trial in endometrial cancer (Faeth release).
Several companies traded higher or lower after hours following their quarterly results, measured against their 4 p.m. ET close. Sanmina was up 20.21% at 7:58 p.m. ET (Sanmina release), and Take-Two Interactive rose 4.32% at 7:59 p.m. ET (Take-Two release). Digital Turbine fell 26.13% and Groupon 18.57%, both at 7:58 p.m. ET (Digital Turbine release; Groupon release). Rocket Lab was down 6.66% at 7:59 p.m. ET (Rocket Lab release). Nvidia was up 1.02% at 7:59 p.m. ET against the same close.
6:04 p.m. ET
S&P 500 posts its best day since April as Sanmina and Digital Turbine move after hours
The closing figures showed a broad rally on Monday. The S&P 500 closed up 2.35%, its best day since April 8, CNBC reported. The Dow Jones Industrial Average gained 2.15% and the Nasdaq Composite rose 2.74%, it reported. Nvidia was little changed in after-hours trading at 6:02 p.m. ET.
Several companies traded sharply higher or lower after hours following their quarterly results, measured against their 4 p.m. ET close. Sanmina, which makes electronics for other companies, was up 19.18% at 5:48 p.m. ET. With its quarterly results, it forecast revenue of $17.5 billion to $19.5 billion for fiscal 2027 (Sanmina release). Take-Two Interactive rose 4.02% at 6 p.m. ET. It kept its forecast of $8.0 billion to $8.2 billion in net bookings, its main sales measure, for the fiscal year ending in March 2027. Its game Grand Theft Auto VI comes out in ten days (Take-Two release; our Take-Two story).
Digital Turbine, a mobile advertising company, fell 24.42% at 6:01 p.m. ET after it reported a 27% rise in quarterly revenue (Digital Turbine release). Groupon, the local deals marketplace, was down 18.28% at 5:38 p.m. ET after its third-quarter results (Groupon release). Rocket Lab fell 5.71% at 6:02 p.m. ET after it reported record quarterly revenue of $268 million (Rocket Lab release; our Rocket Lab story).
4:07 p.m. ET
Stocks close higher as Nvidia ends down 4% and AMD gains 13%
Stocks held their rally into the close. The Dow Jones Industrial Average was up 1,104 points, or 2.15%, CNBC reported in an update at 4:05 p.m. ET. The S&P 500 rose 2.34%, it reported. CNBC tied the rally to lower oil prices and gains in tech shares.
Nvidia closed down 4.27% at $178.67, a smaller fall than at midday. At that price, the drop since Friday came to about $192 billion of market value.
Other chipmakers closed well higher. Advanced Micro Devices ended up 13.26% and Broadcom up 8.78% at 4 p.m. ET. The QQQ fund that tracks the Nasdaq-100 closed up 3.54%.
Telos had the biggest gain in the table below, closing up 48.76% after it raised its 2026 revenue forecast (Telos results, SEC exhibit). Faeth Therapeutics had the biggest fall, ending down 42.49% after it reported early results from a mid-stage cancer trial (Faeth release). The table below gives each stock's close.
1:13 p.m. ET
Dow climbs more than 1,100 points by midday as chipmakers outside Nvidia surge
The rally kept growing through the late morning. The Dow Jones Industrial Average was up 1,113 points, or 2.2%, CNBC reported in an update at 1:05 p.m. ET. The S&P 500 rose 2.3% and the Nasdaq Composite 2.5%, it reported. CNBC tied the gain to lower oil prices and rising tech stocks. The rally lifted the Dow above its Election Day close, CNBC reported.
Nvidia was down 5.41% at 1:07 p.m. ET, a bigger fall than at 10:02 a.m. ET. At that price, the drop since Friday came to about $243 billion of market value. Other chipmakers kept rising. Advanced Micro Devices was up 12% and Broadcom 8%, CNBC reported.
Two more stocks moved alongside quarterly results. Telos, a security software company, rose after it raised its 2026 revenue forecast (Telos results, SEC exhibit). Fervo Energy, a geothermal power company, rose after it reported its third-quarter results (Fervo release). The table below gives each move.
10:04 a.m. ET
Stocks rally after the open as oil slides, and chipmakers outside Nvidia gain
The rally grew once regular trading began. The Dow Jones Industrial Average was up 733 points, or 1.4%, CNBC reported in an update at 9:53 a.m. ET. The S&P 500 rose 1.7% and the Nasdaq Composite 2.1%, it reported. CNBC tied the gain to cheaper oil, with U.S. crude down 3% to about $87 a barrel. The QQQ fund that tracks the Nasdaq-100 was up 2.54% at 10:02 a.m. ET.
Nvidia was down 4.72% at 10:02 a.m. ET, a smaller fall than before the open. At that price, the drop since Friday came to about $212 billion of market value. Other chipmakers rose. Broadcom and Advanced Micro Devices each gained about 5%, CNBC reported. Marvell Technology was up 7.41% and Arm Holdings 4.98% at 10:02 a.m. ET.
More stocks moved alongside company news. Lincoln Educational Services rose after it raised its 2026 revenue forecast (Lincoln release). QXO rose after it said preliminary third-quarter sales grew 79% from a year earlier, helped by two companies it bought (QXO release). Janux Therapeutics fell after it reported first data for its drug JANX011 from an early trial in healthy volunteers (Janux release). ImmunityBio fell after it reported its third-quarter results (ImmunityBio release). The table below gives each move.
9:10 a.m. ET
Dow futures climb 1.3% as Nvidia's loss deepens before the open
Futures added to their gains in the last hour before the open. Dow futures were up 627 points, or 1.3%, and S&P 500 and Nasdaq 100 futures each rose 0.9%, CNBC reported in an update at 8:44 a.m. ET. The SPY fund that tracks the S&P 500 was up 0.91% at 9:04 a.m. ET.
Nvidia's fall grew to 5.81% at 9:04 a.m. ET, or about $261 billion of market value. Advanced Micro Devices rose 3.96% at 9:04 a.m. ET. CNBC tied its earlier gain to an upgrade by Oppenheimer, which raised its rating on the chipmaker to outperform.
More stocks moved alongside results and deal news. Delcath Systems rose after it raised its 2026 revenue forecast (Delcath release). Surgery Partners rose after its buyer raised its cash offer to $25 per share following a rival bid (Surgery Partners release). NRG Energy rose after it agreed to sell six gas power plants for $4 billion (NRG release). Work software maker monday.com fell after it forecast fourth-quarter revenue growth of about 14%, down from 19% in the third quarter (monday.com release). The table below gives each move.
8:14 a.m. ET
Dow futures jump 1% as oil falls, and Nvidia trims its loss
Futures climbed further as oil prices fell. Dow futures were up 507 points, or 1%, and S&P 500 and Nasdaq 100 futures each rose 0.7%, CNBC reported in an update at 7:42 a.m. ET. CNBC tied the gain to cheaper oil. U.S. crude futures dropped to about $88 a barrel, it reported.
Nvidia was down 5.06% at 8:09 a.m. ET, a smaller fall than an hour earlier. At that price, the drop came to about $228 billion of market value. The QQQ fund that tracks the Nasdaq-100 was up 0.89% at 8:08 a.m. ET.
More stocks moved after company news. DoubleDown Interactive rose after its majority owner, DoubleU Games, announced an agreement for a cash tender offer of $16.25 for each American depositary share it does not own (DoubleDown release). Immunovant rose after its drug IMVT-1402 met the main goal of a rheumatoid arthritis trial (Immunovant release). Ionis Pharmaceuticals fell after it cut its 2026 sales forecast for its drug Tryngolza (Ionis release). Faeth Therapeutics fell after it reported early results from a mid-stage cancer trial (Faeth release). The table below gives each move.
7:09 a.m. ET
Nvidia slides on its board's investigation as Dow and Nasdaq futures rise
The week opened with futures higher and Nvidia lower. Dow futures were up 0.76% and Nasdaq 100 futures about 0.5%, CNBC reported in an update at 6:29 a.m. ET. Nvidia fell after its board opened an investigation into reports that its chief executive was the target of a foreign intelligence effort (NVIDIA board statement). Other chip stocks slipped too: Intel, Marvell, Qualcomm and Arm were each down more than 1%, CNBC reported in a story first published at 4:05 a.m. ET.
Overseas, Taiwan's main stock index closed up 4.94%, its biggest one-day gain since July 31, CNBC reported.
Smaller stocks moved beside their own news. Greenfire Resources rose after Strathcona Resources agreed to buy it (Strathcona release). Vir Biotechnology rose after a late-stage trial win (Vir release). Akamai fell after it proposed selling convertible notes, bonds that can later turn into shares (Akamai release). The table below gives each move.
Why is Nvidia stock down today
Nvidia shares fell on Monday after its board said it is investigating reports about its chief executive, CNBC reported. The board said it has no reason to believe company secrets or national security were harmed, and that it still has confidence in him.
In a statement on Sunday at 3 p.m. ET, Nvidia's board said a committee of independent directors, helped by outside lawyers, will run the review. It follows recent reporting that Jensen Huang, the company's founder and chief executive, was the target of a foreign intelligence effort. The board said Huang supports the review and will cooperate with it (NVIDIA board statement).
Nvidia had 24.1 billion shares outstanding on August 21, its latest quarterly filing shows (NVIDIA 10-Q). At Monday's closing price, the fall since Friday came to about $192 billion of market value.
The QQQ fund that tracks the Nasdaq-100 still rose. Intel, Marvell, Qualcomm and Arm slipped early in the morning, CNBC reported. At the 4 p.m. ET close, Advanced Micro Devices was up 13.26% and Broadcom 8.78%. Joachim Klement of Panmure Liberum told CNBC that the impact is currently contained to Nvidia. Nvidia will report its third-quarter results on November 17 and hold a call at 5 p.m. ET that day (Nvidia release).
Friday's session, when chip stocks bounced back after Thursday's selloff, is in StockTitan's November 6 market coverage.
Biggest stock movers today and why
The stocks below moved beside their own company news, with each move read at the regular-session close. Telos, Greenfire Resources and Delcath Systems rose most. Faeth Therapeutics, Janux Therapeutics and Ionis Pharmaceuticals fell most.
| Company | Move | Company news |
|---|---|---|
| Telos (TLS) | +48.76%, regular-session close, 4:00 p.m. ET | Reported third-quarter revenue up 7.3% to $55.2 million and raised its full-year 2026 revenue forecast to $198.2 million to $200.7 million (Telos results, SEC exhibit). |
| Greenfire Resources (GFR) | +38.21%, regular-session close, 4:00 p.m. ET | Strathcona Resources agreed late on Sunday to buy the oil sands producer, offering each holder C$11.00 in cash or 0.25 Strathcona shares; the cash offer is 39% above Greenfire's November 6 close (release). |
| Delcath Systems (DCTH) | +35.77%, regular-session close, 4:00 p.m. ET | The maker of a liver cancer treatment reported third-quarter revenue of $35.1 million, up from $20.6 million a year earlier, and raised its 2026 revenue forecast to a range of $115 million to $117 million (release). |
| Fervo Energy (FRVO) | +26.09%, regular-session close, 4:00 p.m. ET | Reported third-quarter results, with the first unit of its Cape Station geothermal plant in commercial operation and a 396-megawatt power deal signed with Google (Fervo release). |
| Lincoln Educational Services (LINC) | +24.58%, regular-session close, 4:00 p.m. ET | Reported third-quarter revenue up 12.6% to $159.2 million and raised its full-year 2026 revenue forecast (Lincoln release). |
| QXO Inc. (QXO) | +19.08%, regular-session close, 4:00 p.m. ET | Gave preliminary third-quarter net sales of about $4.90 billion, up 79% from a year earlier with two acquired companies included (QXO release). |
| DoubleDown Interactive (DDI) | +15.61%, regular-session close, 4:00 p.m. ET | Its majority owner, DoubleU Games, which holds about 67% of its shares, announced an agreement for a cash tender offer of $16.25 for each American depositary share it does not already own. These are the shares traded in the U.S. (release). |
| Immunovant (IMVT) | +15.13%, regular-session close, 4:00 p.m. ET | The higher dose of its drug IMVT-1402 met the main goal of a trial in hard-to-treat rheumatoid arthritis. The company says the trial may support an approval filing and plans to discuss next steps with the FDA later this year (release). |
| Surgery Partners (SGRY) | +14.01%, regular-session close, 4:00 p.m. ET | Its buyer, HealthSpan Partners, raised its cash offer to $25 per share after a rival bidder offered $28 per share; the board backed the HealthSpan deal, which it said would close sooner (release). |
| Vir Biotechnology (VIR) | +11.75%, regular-session close, 4:00 p.m. ET | Its two-drug treatment for chronic hepatitis delta met the main goal of its phase 3 ECLIPSE 1 trial, and the company plans to file with the FDA in mid-2027 (release). |
| NRG Energy (NRG) | +10.45%, regular-session close, 4:00 p.m. ET | It agreed to sell six natural gas power plants to LS Power for $4 billion in cash, and plans to use the money for share buybacks and to pay down debt (release). |
| Powerfleet (AIOT) | +3.72%, regular-session close, 4:00 p.m. ET | The maker of software that tracks vehicles and equipment reported record quarterly revenue of $115.7 million, up 4% from a year earlier, and kept its forecast for its 2027 fiscal year (release). |
| Faeth Therapeutics (FTH) | -42.49%, regular-session close, 4:00 p.m. ET | It reported early results from a mid-stage trial of its combination of two oral drugs, given with chemotherapy, in advanced endometrial cancer: tumors shrank in 33% of the patients it could assess (release). |
| Janux Therapeutics (JANX) | -27.62%, regular-session close, 4:00 p.m. ET | Reported first data for its drug JANX011 from an early trial in 25 healthy volunteers (Janux release). |
| Ionis Pharmaceuticals (IONS) | -21.36%, regular-session close, 4:00 p.m. ET | It cut its 2026 sales forecast for its drug Tryngolza to about $50 million, from a range of $100 million to $110 million, as the launch grew more slowly than it expected (release). |
| ImmunityBio (IBRX) | -17.66%, regular-session close, 4:00 p.m. ET | Reported third-quarter product revenue of $48.7 million, up 53% from a year earlier (ImmunityBio release). |
| monday.com (MNDY) | -9.10%, regular-session close, 4:00 p.m. ET | The work software maker reported third-quarter revenue up 19% to $377.5 million and forecast fourth-quarter revenue growth of about 14% (release). |
| Ceva (CEVA) | -8.34%, regular-session close, 4:00 p.m. ET | The chip design licensor reported third-quarter revenue of $29.1 million, up 2% from a year earlier, and said a large licensing deal it expected in the quarter was signed early in the fourth quarter instead (release). |
| NVIDIA (NVDA) | -4.27%, regular-session close, 4:00 p.m. ET | Its board opened an independent investigation after reports that chief executive Jensen Huang was the target of a foreign intelligence effort (release). |
| Akamai Technologies (AKAM) | -3.37%, regular-session close, 4:00 p.m. ET | It proposed selling $2.2 billion of convertible notes due 2028 and 2031, partly to repay notes due in 2027 and to fund its cloud business (release). |
Source: StockTitan real-time Nasdaq data and StockTitan's movers board, against each stock's November 6 close; company releases linked in each row.
The Greenfire deal still needs two-thirds of the votes at both companies' shareholder meetings, a separate vote of the smaller holders, and court and competition approvals. Waterous Energy Fund, which owns 72% of Greenfire and 57% of Strathcona, has agreed to back it and take shares (Strathcona release).
At week 48 of Vir's trial, 44% of treated patients had both no detectable virus and normal liver enzyme levels, the trial's main goal. In the group whose treatment started later, none met that goal at week 12. Counting the virus alone, 79% of treated patients had none left that tests could detect (Vir release).
Akamai said it will buy hedges meant to limit how many new shares the notes create on conversion, and will sell warrants, which could add shares of their own (Akamai release).
What to watch tomorrow
The next regular session opens on Tuesday, November 10, at 9:30 a.m. ET. Stock futures were little changed on Monday night before that morning's inflation report, CNBC reported.
- Tuesday, November 10, 8:30 a.m. ET: the consumer price index for October (BLS schedule), also on StockTitan's economic calendar. Economists polled by Dow Jones expect prices to rise 0.3% from September, and 0.2% leaving out food and energy, CNBC reported.
- Tuesday, before the open: Sea Limited, which runs the Shopee shopping platform, and the website builder Wix report quarterly results (Sea release; Wix release).
- Tuesday, after the close: Sonos, the speaker maker, reports results for its fiscal fourth quarter, with a call at 4:30 p.m. ET (Sonos release).
- This week: CoreWeave, Cisco and Applied Materials report quarterly results, CNBC reported. Every company reporting this week is in StockTitan's Earnings Calendar for the Week of November 9, 2026.
- Tuesday, November 17: Nvidia's third-quarter results, with a call at 5 p.m. ET (Nvidia release).
- January 2027: the Greenfire and Strathcona shareholder meetings on the deal, with closing expected shortly after (Strathcona release).
- First quarter of 2027: results of Vir's other two late-stage hepatitis delta trials, ECLIPSE 2 and ECLIPSE 3 (Vir release).
Our numbers
These figures are our calculations from the sources linked in this article.
- About $192 billion: Nvidia's market value lost since Friday, from the 24.1 billion shares on its latest 10-Q cover times the $7.97 fall from its November 6 close of $186.64 to its official close of $178.67 on November 9 in StockTitan real-time Nasdaq data. The same sum at the earlier updates gave about $228 billion at 8:09 a.m. ET, $261 billion at 9:04 a.m. ET, $212 billion at 10:02 a.m. ET and $243 billion at 1:07 p.m. ET.
Frequently asked questions
Stocks rose on November 9 as oil prices fell, with the Dow closing up 1,104 points, or 2.15%, CNBC reported. Nvidia closed down 4.27% after its board opened an investigation into reports that its chief executive was the target of a foreign intelligence effort. After the close, Sanmina rose and Digital Turbine fell in after-hours trading following their quarterly results.
Nvidia closed down 4.27% at $178.67 on November 9. Its board opened an independent investigation after reports that chief executive Jensen Huang was the target of a foreign intelligence effort. The board said it has no reason to believe company secrets were compromised.
Greenfire ended the regular session up 38.21% on November 9. Strathcona Resources agreed late on Sunday to buy it for C$11.00 in cash or 0.25 Strathcona shares per Greenfire share.
Faeth ended the regular session down 42.49% on November 9. That morning it reported early results from a mid-stage trial of its two-drug combination, given with chemotherapy, in advanced endometrial cancer (Faeth release).
Delcath ended the regular session up 35.77% on November 9. That morning it reported third-quarter revenue of $35.1 million, up from $20.6 million a year earlier, and raised its 2026 revenue forecast.
DoubleDown ended the regular session up 15.61% on November 9. That morning its majority owner, DoubleU Games, announced an agreement for a cash tender offer of $16.25 for each American depositary share it does not own. These are the shares traded in the U.S.
Ionis ended the regular session down 21.36% on November 9. That morning it cut its 2026 sales forecast for its drug Tryngolza to about $50 million, from a range of $100 million to $110 million.
Sources
- StockTitan: live market coverage, November 6, 2026
- StockTitan: Earnings Calendar for the Week of November 9, 2026
- StockTitan economic calendar
- Statement from NVIDIA Board of Directors
- Strathcona Resources agreement to acquire Greenfire Resources release
- Vir Biotechnology ECLIPSE 1 phase 3 results release
- Akamai proposed convertible notes offering release
- DoubleU Games and DoubleDown Interactive tender offer agreement release
- Immunovant corporate updates and quarterly results release
- Ionis third quarter 2026 results release
- Faeth PIK-201 phase 2 topline results release
- Delcath Systems third quarter 2026 results release
- Powerfleet second quarter fiscal 2027 results release
- Surgery Partners and HealthSpan Partners amended merger agreement release
- NRG Energy $4 billion asset sale release
- monday.com third quarter 2026 results release
- Ceva third quarter 2026 results release
- NVIDIA third-quarter results conference call release
- Lincoln Educational Services third quarter 2026 results release
- QXO third quarter 2026 preliminary financial information release
- Janux Therapeutics JANX011 phase 1 data release
- ImmunityBio third quarter 2026 results release
- NVIDIA quarterly report on Form 10-Q for the quarter ended July 26, 2026
- Bureau of Labor Statistics: Consumer Price Index release schedule